Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 0 | 0 | 7,500 | 0 | 0 |
| Gross Profit | N/A | N/A | 7,500 | N/A | N/A |
| Operating Expenses | 96,336 | 94,229 | 80,238 | 77,477 | 73,676 |
| Operating Income | -96,336 | -94,229 | -72,738 | -77,477 | -73,676 |
| Other Income | 6,117 | 8,897 | 8,118 | 7,944 | 10,566 |
| Pre-tax Income | -90,219 | -85,332 | -64,620 | -69,533 | -63,110 |
| Income Tax | 677 | -626 | 427 | -3,848 | -320 |
| Net Income Continuous | -90,896 | -84,706 | -65,047 | -65,685 | -62,790 |
| Net Income | $-90,896 | $-84,706 | $-65,047 | $-65,685 | $-62,790 |
| EPS Basic Total Ops | -1.15 | -1.07 | -0.83 | -0.83 | -0.81 |
| EPS Basic Continuous Ops | -1.15 | -1.07 | -0.83 | -0.84 | -0.81 |
| EPS Diluted Total Ops | -1.15 | -1.07 | -0.83 | -0.83 | -0.81 |
| EPS Diluted Continuous Ops | -1.15 | -1.07 | -0.83 | -0.84 | -0.81 |
| EPS Diluted Before Non-Recurring Items | -1.15 | -1.07 | -0.83 | -0.84 | -0.81 |
| EBITDA(a) | $-95,695 | $-93,597 | $-72,079 | $-76,811 | $-73,009 |